Insights On Drug Development
-
Adare Pharma Solutions Pessano Site Tour
2/27/2025
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
-
Meet Singota's 'Dr. Impossible'
2/26/2025
Explore how Dr. Shehaab Savliwala, a leading formulation scientist at Singota Solutions, transforms complex pharmaceutical challenges into breakthroughs, leveraging expertise in nanoparticle formulations and innovative drug delivery
-
Biologics Technology Transfer Guidebook
2/26/2025
Explore why technology transfer is a critical component in mammalian biologic drug development and manufacturing with the essential guide to biologics tech transfer that covers key strategies, best practices, and critical considerations.
-
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success
2/26/2025
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates
2/20/2025
Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.
-
From Research To Reality: Overcoming CMC Challenges In Cell & Gene Therapy
2/20/2025
Explore the importance of adopting a Quality by Design (QbD) approach in the development process while integrating regulatory and CMC strategies for maximum efficiency and benefit.
-
Formulation Through Manufacturing Under One Roof
2/18/2025
Partner with a CDMO that understands the unique challenges of emerging biopharma, providing expert guidance in formulation development, manufacturing, and regulatory navigation.
-
LC/MS Method For Measurement In Human Plasma
2/17/2025
According to the researchers, this plasma-based measurement has the potential to serve as a critical pharmacodynamic biomarker, facilitating the assessment of novel therapeutic approaches.
-
LC/MS/MS Analysis Of Coproporphyrin 1, Coproporphyrin 3 In Human Plasma
2/17/2025
This innovative approach holds promise for reducing the need for extensive clinical drug-drug interaction studies, potentially streamlining the drug development process.